Pfizer Inc.

NYSE:PFE   3:59:57 PM EDT
43.95
-0.24 (-0.54%)
: $43.85 -0.10 (-0.23%)
Products

Pfizer-Biontech Covid-19 Vaccine Comirnaty Receives Full U.S. FDA Approval For Individuals 16 Years And Older

Published: 08/23/2021 16:11 GMT
Pfizer Inc. (PFE) - Pfizer-biontech Covid-19 Vaccine Comirnaty® Receives Full U.S. FDA Approval for Individuals 16 Years and Older.
Biontech - Co & Pfizer Intend to Submit Supplemental Bla to Support Potential Full FDA Approval of Comirnaty in Individuals 12 Through 15 Years of Age.
Biontech - to Submit Supplemental Bla for Full FDA Approval of Comirnaty for 12 - 15 Yrs Once Data Out to 6 Months After Second Dose Are Available.